A Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Study To Evaluate Efficacy and Safety of XP12B for the Treatment of Menorrhagia.

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 07 Oct 2010

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

06 Oct 2010 Results published in full in the the October issue of Obstetrics and Gynecology, according to a Ferring Pharmaceuticals media release.
01 Oct 2010 Results have been published in Obstetrics & Gynecology.
19 May 2010 Results data were presented at The American College of Obstetricians and Gynecologists 58th Annual Clinical Meeting, accoring to a Ferring Pharmaceuticals media release.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com